Positron emission tomography targeting the prostate specific membrane antigen (PSMA-PET) has been implemented in the staging of primary PCa [17], and its excellent performance for ITM detection has been demonstrated by several studies [18,19,20,21,22,23]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.